A detailed history of Advisor Group Holdings, Inc. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 28 shares of ANIP stock, worth $1,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 27 3.7%
Holding current value
$1,578
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$54.33 - $65.72 $54 - $65
1 Added 3.7%
28 $1,000
Q2 2024

Aug 13, 2024

SELL
$58.53 - $68.82 $61,046 - $71,779
-1,043 Reduced 97.48%
27 $1,000
Q1 2024

May 10, 2024

SELL
$54.2 - $69.69 $8,130 - $10,453
-150 Reduced 12.3%
1,070 $73,000
Q4 2023

Feb 12, 2024

SELL
$48.72 - $65.43 $12,228 - $16,422
-251 Reduced 17.06%
1,220 $67,000
Q3 2023

Nov 13, 2023

SELL
$50.28 - $64.61 $5,430 - $6,977
-108 Reduced 6.84%
1,471 $85,000
Q2 2023

Aug 10, 2023

BUY
$37.29 - $53.83 $40,534 - $58,513
1,087 Added 220.93%
1,579 $84,000
Q1 2023

May 12, 2023

SELL
$37.61 - $45.72 $4,061 - $4,937
-108 Reduced 18.0%
492 $19,000
Q4 2022

Feb 10, 2023

BUY
$31.9 - $41.95 $5,167 - $6,795
162 Added 36.99%
600 $24,000
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $4,146 - $5,283
-139 Reduced 24.09%
438 $14,000
Q2 2022

Aug 10, 2022

BUY
$23.09 - $33.46 $13,022 - $18,871
564 Added 4338.46%
577 $17,000
Q1 2022

May 04, 2022

SELL
$26.91 - $47.15 $188 - $330
-7 Reduced 35.0%
13 $0
Q1 2021

May 13, 2021

SELL
$28.4 - $36.14 $5,680 - $7,228
-200 Reduced 90.91%
20 $1,000
Q4 2020

Feb 10, 2021

SELL
$23.69 - $31.47 $2,676 - $3,556
-113 Reduced 33.93%
220 $6,000
Q3 2020

Nov 12, 2020

BUY
$26.38 - $33.1 $158 - $198
6 Added 1.83%
333 $9,000
Q2 2020

Aug 14, 2020

SELL
$29.93 - $50.1 $21,070 - $35,270
-704 Reduced 68.28%
327 $11,000
Q1 2020

May 18, 2020

BUY
$30.35 - $67.14 $31,290 - $69,221
1,031 New
1,031 $42,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.